As of Apr 25
| +0.07 / +2.70%|
The 4 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 8.50, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +219.55% increase from the last price of 2.66.
The current consensus among 4 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.